Literature DB >> 15372245

Clinicoradiologic subtypes of Marchiafava-Bignami disease.

Alexander Heinrich1, Uwe Runge, Alexander V Khaw.   

Abstract

The clinical diagnosis of Marchiafava-Bignami disease (MBD) has considerably changed during recent decades with brain MRI providing the opportunity of a reliable in-vivo diagnosis. However, semiologic and neuroimaging characteristics of the currently known spectrum of MBD have not been investigated systematically, and knowledge of clinicoradiologic associations is sketchy. We report an illustrative case with limited callosal involvement on MRI and a favorable outcome and have reviewed literature on clinical and radiologic features in 50 cases of MBD diagnosed in vivo since 1985. Our reviewed data suggest the differentiation of two clinicoradiologic subtypes: Type A is characterized by major impairment of consciousness, T2-hyperintense swelling of the entire corpus callosum on early MRI and poor outcome. Type B shows at most slight impairment of consciousness, partial callosal lesions on MRI and a favorable outcome. Differentiation of these clinicoradiologic subtypes may help resolve inconsistencies of the established clinical classification resulting from new insights into the clinical course and prognosis of MBD by structural neuroimaging.

Entities:  

Mesh:

Year:  2004        PMID: 15372245     DOI: 10.1007/s00415-004-0566-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  48 in total

1.  Neuroradiologic abnormalities in Marchiafava-Bignami disease of benign evolution.

Authors:  G Izquierdo; M A Quesada; J Chacon; J Martel
Journal:  Eur J Radiol       Date:  1992 Jul-Aug       Impact factor: 3.528

2.  Marchiafava-Bignami disease: cranial MRI and SPECT findings.

Authors:  Yahya Celik; Meryem Kaya; Semra Sengün; Ufuk Utku
Journal:  Clin Neurol Neurosurg       Date:  2002-09       Impact factor: 1.876

3.  Callosal bleeding in a case of Marchiafava-Bignami disease.

Authors:  M Kamaki; M Kawamura; H Moriya; K Hirayama
Journal:  J Neurol Sci       Date:  1996-03       Impact factor: 3.181

4.  An autopsy case of Marchiafava-Bignami disease with peculiar chronological CT changes in the corpus callosum: neuroradiopathological correlations.

Authors:  J Y Shiota; I Nakano; M Kawamura; K Hirayama
Journal:  J Neurol Sci       Date:  1996-03       Impact factor: 3.181

5.  Marchiafava-Bignami disease: reversibility of neuroimaging abnormality.

Authors:  A Gass; G Birtsch; M Olster; A Schwartz; M G Hennerici
Journal:  J Comput Assist Tomogr       Date:  1998 May-Jun       Impact factor: 1.826

6.  [Marchiafava-Bignami disease: development with flare-up].

Authors:  O Moreaud; N Dufossé; J Pellat
Journal:  Rev Neurol (Paris)       Date:  1996 Aug-Sep       Impact factor: 2.607

7.  Computerized tomography and MRI in Marchiafava-Bignami disease.

Authors:  S Bracard; D Claude; H Vespignani; M Almeras; M Carsin; H Lambert; L Picard
Journal:  J Neuroradiol       Date:  1986       Impact factor: 3.447

8.  [Marchiafava-Bignani disease of good prognosis. Two cases].

Authors:  P Alla; C Carrère; G Dupont; B Gilles; J Valance; P Carli
Journal:  Presse Med       Date:  2000-06-17       Impact factor: 1.228

9.  Incomplete split-brain syndrome in a patient with chronic Marchiafava-Bignami disease.

Authors:  W Kalckreuth; P Zimmermann; B Preilowski; C W Wallesch
Journal:  Behav Brain Res       Date:  1994-10-20       Impact factor: 3.332

10.  Regional cerebral glucose metabolism and blood flow in a patient with Marchiafava-Bignami disease.

Authors:  K Ishii; Y Ikerjiri; M Sasaki; H Kitagaki; E Mori
Journal:  AJNR Am J Neuroradiol       Date:  1999-08       Impact factor: 3.825

View more
  29 in total

1.  Alcohol consumption and premotor corpus callosum in older adults.

Authors:  Dimitrios Kapogiannis; Jason Kisser; Christos Davatzikos; Luigi Ferrucci; Jeffrey Metter; Susan M Resnick
Journal:  Eur Neuropsychopharmacol       Date:  2012-03-06       Impact factor: 4.600

2.  Cerebral microhemorrhage in Marchiafava-Bignami disease detected by susceptibility-weighted imaging.

Authors:  Ryuta Kinno; Masahiro Yamamoto; Takahiro Yamazaki; Yoshiyuki Owan; Toshiya Fukui; Eriko Kinugasa
Journal:  Neurol Sci       Date:  2012-07-10       Impact factor: 3.307

3.  Acute Marchiafava-Bignami disease with callosal, cortical, and white matter involvement.

Authors:  Lojana Tuntiyatorn; Jiraporn Laothamatas
Journal:  Emerg Radiol       Date:  2007-09-09

4.  Marchiafava-Bignami disease: a rare entity with a poor outcome.

Authors:  Paulo Eduardo Mestrinelli Carrilho; Marcius Benigno Marques Dos Santos; Larisa Piasecki; Amaury Cezar Jorge
Journal:  Rev Bras Ter Intensiva       Date:  2013-03

5.  Marchiafava-Bignami disease with widespread lesions and complete recovery.

Authors:  C-S Tung; S-L Wu; J-C Tsou; S-P Hsu; H-C Kuo; H-W Tsui
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-17       Impact factor: 3.825

6.  Bilateral middle cerebellar peduncles involvement a malnourished man with Marchiafava-Bignami disease.

Authors:  Yaoyao Shen; Zhijuan Cheng; Tingmin Dai; Hongbing Nie
Journal:  Neurol Sci       Date:  2018-10-18       Impact factor: 3.307

7.  Marchiafava-Bignami disease-like lesions due to central nervous system lupus.

Authors:  Yoichiro Kashiwagi; Takahiko Horiuchi; Chie Harashima; Fujio Matsubara; Shin-Ichi Harashima
Journal:  BMJ Case Rep       Date:  2010-11-29

8.  Acute Marchiafava-Bignami disease presenting as reversible dementia in a chronic alcoholic.

Authors:  Vineet Sehgal; Praveen Kesav; M Modi; Chirag K Ahuja
Journal:  BMJ Case Rep       Date:  2013-02-15

Review 9.  Neurology of Nutritional Deficiencies.

Authors:  Kristin L Miller; Gabriela Trifan; Fernando D Testai
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-26       Impact factor: 5.081

10.  Partial interhemispheric disconnection syndrome (P-IHDS) secondary to Marchiafava-Bignami disease type B (MBD-B).

Authors:  Carlo Canepa; Lorena Arias
Journal:  BMJ Case Rep       Date:  2016-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.